NCT00499798View on ClinicalTrials.gov

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2014

Conditions
Brain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility
Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00499798 - Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors | Biotech Hunter | Biotech Hunter